Cargando…
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure
With the development of regenerative medicine, a variety of mesenchymal stem cells (MSCs) are increasingly considered for the treatment of premature ovarian failure (POF). Reportedly, bone marrow-derived MSCs (BMSCs) improve the ovarian reserve, which mainly depends on homing and paracrine activitie...
Autores principales: | He, Yantao, Chen, Dongmei, Yang, Lingling, Hou, Qiaoni, Ma, Huiming, Xu, Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172726/ https://www.ncbi.nlm.nih.gov/pubmed/30286808 http://dx.doi.org/10.1186/s13287-018-1008-9 |
Ejemplares similares
-
Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
por: Huang, Yanjing, et al.
Publicado: (2022) -
Corrigendum: Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects
por: Huang, Yanjing, et al.
Publicado: (2022) -
The Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Mice Premature Ovarian Failure
por: Wang, Shufang, et al.
Publicado: (2013) -
The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure
por: Umer, Amna, et al.
Publicado: (2022) -
Skin-Derived Mesenchymal Stem Cells Help Restore Function to Ovaries in a Premature Ovarian Failure Mouse Model
por: Lai, Dongmei, et al.
Publicado: (2014)